Adora Ndu
Director/Board Member bei DBV TECHNOLOGIES
Vermögen: 83 628 $ am 31.03.2024
Profil
Dr. Adora Ndu ist VP-World Wide Research & Development bei BioMarin Pharmaceutical, Inc. Sie ist Mitglied des Board of Directors bei DBV Technologies SA. Dr. Ndu war zuvor als Mitglied der University of Maryland tätig. Sie erhielt ihren Abschluss an der University of Maryland Francis King Carey School of Law und einen Doktortitel am Howard University College of Medicine.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
12.10.2023 | 4 381 ( 0,00% ) | 81 005 $ | 31.03.2024 | |
DBV TECHNOLOGIES SA
0,00% | 06.02.2024 | 1 825 ( 0,00% ) | 2 623 $ | 31.03.2024 |
Aktive Positionen von Adora Ndu
Unternehmen | Position | Beginn |
---|---|---|
DBV TECHNOLOGIES | Director/Board Member | 19.05.2021 |
BRIDGEBIO PHARMA, INC. | General Counsel | 01.01.2022 |
ACADIA PHARMACEUTICALS INC. | Director/Board Member | 10.10.2022 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | - |
Ehemalige bekannte Positionen von Adora Ndu
Unternehmen | Position | Ende |
---|---|---|
BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01.01.2022 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Adora Ndu
The University of Maryland Francis King Carey School of Law | Graduate Degree |
Howard University College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
DBV TECHNOLOGIES | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |